Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
Trends in Pharmacological Sciences|February 11, 1992
Molecular biology of dopamine receptorsD R Sibley, F J MonsmaSynapse (New York, N.Y.)|January 1, 1989
Direct demonstration of D1 dopamine receptors in the bovine parathyroid gland using the D1 selective antagonist [125I]-SCH 23982F J Monsma, D R SibleyNeurochemistry International|May 28, 2010
Differential desensitization of muscarinic receptor-stimulated phosphoinositide turnover in the rat brainF J Monsma, L G Abood, W HossInternational Review of Neurobiology|January 1, 1993
Molecular neurobiology of dopaminergic receptorsD R Sibley, F J Monsma, Y ShenBiochemical Pharmacology|June 15, 1988
Inhibition of phosphoinositide turnover by selective muscarinic antagonists in the rat striatum. Correlation with receptor occupancyF J Monsma, L G Abood, W HossBrain Research|July 17, 1989
Identification and characterization of D1 and D2 dopamine receptors in cultured neuroblastoma and retinoblastoma clonal cell linesF J Monsma, D L Brassard, D R SibleyJournal of Neurochemistry|November 3, 1998
Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptorF G Boess, F J Monsma, A J SleightJournal of Neurochemistry|April 11, 1990
Expression of functional D2 dopamine receptors following differentiation of Y-79 human retinoblastoma cellsF J Monsma, A C Barton, D R SibleyThe Journal of Biological Chemistry|June 14, 1996
Structure-activity relationship studies on the novel neuropeptide orphanin FQR K Reinscheid, A Ardati, F J Monsma, et al.Life Sciences|January 11, 1992
Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatmentS X Xu, F J Monsma, D R Sibley, et al.Pageof 6